Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taxon Biosciences was a private microbiome discovery company focused primarily on agricultural biologicals rather than human therapeutics. The company used genomics, bioinformatics, microbiology, and cultivation-based tools to profile microbial communities and identify microbial-based product opportunities across agriculture, environmental, energy, and selected life science applications. Its core value proposition was a platform for discovering and developing beneficial microbial consortia and related biological products. Taxon was founded in 2000 in California and was acquired by DuPont in 2015 to strengthen DuPont's crop biologicals discovery capabilities. Based on the available evidence, Taxon should be classified mainly as an agricultural/industrial biotechnology platform company, not a clinical-stage healthcare biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taxon Biosciences.